Skip to main content
. 2017 Apr 18;8(26):42466–42477. doi: 10.18632/oncotarget.17198

Figure 4. Caspase-3 activation is not enhanced by combination treatment.

Figure 4

Cells were treated with pemetrexed (20 μM), cisplatin (40 μM), or cSBL (1 μM) for 72 h. (A) Cleaved (activated) caspase-3 was detected using western blot analysis. (B) Caspase-3 activity was analyzed using a Caspase-Glo 3/7 assay. *p < 0.05; n.s.: not significant.